This Viewpoint discusses lessons learned from a recent article from the Schizophrenia Working Group of the Psychiatric Genomics Consortium on 108 schizophrenia-associated genetic loci.
This study assesses dendritic spine loss in the dorsolateral prefrontal cortex in individuals with schizophrenia and individuals with bipolar disorder and suggests that the 2 disorders may share some common pathophysiological features.
This randomized clinical trial shows that cognitive behavior therapy that includes exposure therapy to treat prolonged grief disorder facilitates emotional responses that reduce symptoms.
This prospective study does not identify any involvement of changes in brain norepinephrine transporter availability or distribution in the pathogenesis of attention-deficit/hyperactivity disorder.
This study assesses cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders.
This study presents preliminary evidence of dopamine sensitization in a socially excluded group of people with hearing impairment.
This prospective cohort study suggests that activity may alleviate depressive symptoms in the general population, whereas depressive symptoms in early adulthood may be a barrier to physical activity.
This meta-analysis supports a proof-of-concept concerning use of anti-inflammatory treatment in depression.
This study concludes that the robust joint test be used in candidate-gene and genome-wide association studies of psychiatric outcomes that consider environmental interactions.
This cross-sectional study conducted in 18 countries reports significant inverse associations between subjective social status and numerous DSM-IV mental disorders.
This meta-analysis reports that the average treatment change associated with placebo treatment in antipsychotic trials increased since 1960, while the change associated with medication treatment decreased.